当前位置：首页 SCI期刊 SCIE期刊医学中科院1区 JCRQ1 期刊介绍(非官网)

Jacc-cardiovascular InterventionsSCIE

国际简称：JACC-CARDIOVASC INTE 参考译名：Jacc-心血管干预

中科院分区
1区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：1936-8798; E-ISSN：1876-7605; 是否OA：未开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：United States; 出版商：Elsevier Inc.; 出版语言：English; 出版周期：Monthly; 出版年份：2008; 研究方向：CARDIAC & CARDIOVASCULAR SYSTEMS

评价信息：: 影响因子：11.7; H-index：107; CiteScore指数：11.6; SJR指数：2.886; SNIP指数：2.302

发文数据：: Gold OA文章占比：66.94%; 研究类文章占比：90.23%; 年发文量：174; 自引率：0.0884...; 开源占比：0.0963; 出版撤稿占比：0; 出版国人文章占比：0.02; OA被引用占比：0.0878...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Jacc-cardiovascular Interventions期刊介绍

JACC: Cardiovascular Interventions encompasses the entire field of interventional cardiovascular medicine, including cardiac (coronary and non-coronary) peripheral and cerebrovascular interventions. JACC: Cardiovascular Interventions publishes studies that will impact the practice of interventional cardiovascular medicine including:

• Clinical trials that provide evidence to inform and alter practice guidelines • Experimental studies that point to improved technologies and mechanistic understanding • In-depth discussions of topics of interest by respected experts in the field.

Since interventional cardiovascular medicine is a highly visual specialty, the print journal is augmented by electronic publication allowing the latest technologies to be employed.

期刊简介Jacc-cardiovascular Interventions期刊介绍

《Jacc-cardiovascular Interventions》自2008出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：偏慢,4-8周
国际TOP期刊
医学
CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
中科院1区
非预警

Cite Score数据（2024年最新版）Jacc-cardiovascular Interventions Cite Score数据

CiteScore：11.6
SJR：2.886
SNIP：2.302

学科类别	分区	排名	百分位
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q1	25 / 387	93%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Jacc-cardiovascular Interventions 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	1区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Jacc-cardiovascular Interventions JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q1	10 / 220	95.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q1	10 / 220	95.68%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA1184
GERMANY (FED REP GER)262
Italy236
Canada181
England171
Japan158
Netherlands149
France143
Spain140
Switzerland129

本刊中国学者近年发表论文

1、Preclinical Evaluation of a Novel Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold in Porcine Coronary Artery at 6 Months
Author: Jian-Feng Zheng, Hong Qiu, Yuan Tian, Xiao-Ying Hu, Tong Luo, Chao Wu, Yi Tian, Yue Tang, Lai-Feng Song, Li Li, Liang Xu, Bo Xu, Run-Lin Gao

Journal: JACC-Cardiovascular Interventions, 2019, Vol.12, 245-255, DOI:10.1016/j.jcin.2018.10.020
2、5 Years of Serial Intravascular Imaging Outcomes of XINSORB Sirolimus-Eluting Bioresorbable Vascular Scaffold
Author: Yizhe Wu, Li Shen, Jiasheng Yin, Jiahui Chen, Lei Ge, Junbo Ge

Journal: JACC-Cardiovascular Interventions, 2019, Vol., , DOI:10.1016/j.jcin.2018.11.029
3、Occlusion of an Extremely Large Left Atrial Appendage Using the “Double-LAmbre Technique”
Author: Chak-yu So, Kwok-fai Leung, Yat-yin Lam, Bryan P. Yan

Journal: JACC-Cardiovascular Interventions, 2018, Vol., , DOI:10.1016/j.jcin.2018.10.015
4、Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial
Author: Yundai Chen, Lei Gao, Qin Qin, Shaoliang Chen, Jun Zhang, Hui Chen, Lefeng Wang, Zening Jin, Yang Zheng, Zheng Zhang, Hui Li, Xue Li, Guosheng Fu, Lian Chen, Zhijun Sun, Yu Wang, Qinhua Jin, Feng Cao, Jun Guo, Yanyan Zhao, Changdong Guan, Wei Li, Bo Xu, Yundai Chen, Yundai Chen, Shaoliang Chen, Bo Xu, Yong Zeng, Qing Yang, Jian Zhang, Yundai Chen, Lei Gao, Lian Chen, Zhijun Sun, Yu Wang, Qinhua Jin, Feng Cao, Jun Guo, Qin Qin, Jingyu Yang, Shaoliang Chen, Xiaobo Li, Jun-jie Zhang, Shoujie San, Zhen Ge, Liang Chen, Wei You, Zhiming Wu, Nailiang Tian, Jun Zhang, Jun Wang, Jinguo Fu, Heping Niu, Hui Chen, Siwen Liang, Huiqiang Zhao, Dongbao Li, Zening Jin, Duo Yang, Shuai Meng, Lefeng Wang, Zhiyong Zhang, Yang Zheng, Shouyan Hao, Zheng Zhang, Ming Bai, Cunrui Zhao, Hui Li, Manqing Wang, Jijia Wang, Xue Li, Yusheng Xue, Bin Wang, Guosheng Fu, Fuyu Qiu, Yanbo Zhao, Chongyin Jin, Shengjie Xu, Lili Wu

Journal: JACC-Cardiovascular Interventions, 2018, Vol.11, 2368-2377, DOI:10.1016/j.jcin.2018.09.010
5、Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial
Author: Yida Tang, Shubin Qiao, Xi Su, Yundai Chen, Zening Jin, Hui Chen, Biao Xu, Xiangqing Kong, Wenyue Pang, Yong Liu, Zaixin Yu, Xue Li, Hui Li, Yanyan Zhao, Yang Wang, Wei Li, Jian Tian, Changdong Guan, Bo Xu, Runlin Gao, Runlin Gao, Shubin Qiao, Runlin Gao, Bo Xu, Yida Tang, Shubin Qiao, Xi Su, Yong Zeng, Qing Yang, Jian Zhang, Runlin Gao, Shubin Qiao, Bo Xu, Yida Tang, Changdong Guan, Jian Tian, Jue Chen, Yongjian Wu, Hongbin Yan, Yuejin Yang, Xi Su, Min Wang, Jiangyou Wang, Wenjie Xu, Yundai Chen, Qinhua Jin, Zening Jin, Duo Yang, Shuai Meng, Hui Chen, Siwen Liang, Daokuo Yao, Dongbao Li, Biao Xu, Jie Song, Qing Dai, Kun Wang, Lina Kang, Lian Wang, Xiangqing Kong, Hui Wang, Liansheng Wang, Wenyue Pang, Jiye Wan, Yong Liu, Liudong Wei, Feng He, Xiaochun Xing, Zaixin Yu, Duanzheng Wang, Ran Jin, Xue Li, Yusheng Xue, Bin Wang, Hui Li, Manqing Wang, Jijia Wang

Journal: JACC-Cardiovascular Interventions, 2018, Vol.11, 2381-2392, DOI:10.1016/j.jcin.2018.09.009
6、Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I
Author: Yongle Xu, Xin Jia, Jiwei Zhang, Baixi Zhuang, Weiguo Fu, Danming Wu, Feng Wang, Yu Zhao, Pingfan Guo, Wei Bi, Shenming Wang, Wei Guo

Journal: JACC-Cardiovascular Interventions, 2018, Vol.11, 2347-2353, DOI:10.1016/j.jcin.2018.07.041
7、Pulmonary Artery Denervation Significantly Increases 6-minute Walk Distance for Patients with Combined Pre- and Post-capillary Pulmonary Hypertension Associated with the Left Heart Failure: PADN-5 Study
Author: Hang Zhang, Juan Zhang, Mengxuan Chen, Dujiang Xie, Jing Kan, Wande Yu, Xiaobo Li, Tian Xu, Yue Gu, Jianzeng Dong, Hong Gu, Yaling Han, Shao-Liang Chen

Journal: JACC-Cardiovascular Interventions, 2018, Vol., , DOI:10.1016/j.jcin.2018.09.021
8、First Report of Drug-Coated Balloon Angioplasty for Vertebral Artery Origin Stenosis
Author: YaBing Wang, Yan Ma, Peng Gao, Yanfei Chen, Bin Yang, Liqun Jiao

Journal: JACC-Cardiovascular Interventions, 2018, Vol.11, 500-502, DOI:10.1016/j.jcin.2017.09.040